Stay updated on IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Sign up to get notified when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.

Latest updates to the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page
- Check4 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check33 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check62 days agoChange DetectedThe web page has updated its version from v2.15.0 to v2.15.2 and has added a date of April 27, 2025. However, there are no significant changes to core content, names, pricing, or availability.SummaryDifference1.0%
- Check76 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check84 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for March 6, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.7%
Stay in the know with updates to IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.